If you have walked down a pharmacy aisle recently, you know that acetaminophen—best known as Tylenol—is marketed as the safest pain reliever for pregnant women. For decades, it was the only real choice.
On July 13, 2026, a federal appeals court dramatically shook up that narrative.
The Second U.S. Circuit Court of Appeals in Manhattan revived more than 500 private lawsuits against Kenvue, the consumer health company spun off from Johnson & Johnson. These lawsuits represent thousands of families. They argue that taking Tylenol during pregnancy led to their children developing autism spectrum disorder or attention-deficit/hyperactivity disorder, commonly known as ADHD.
This decision does not mean the science is settled. It does not mean Tylenol is officially declared dangerous. But it completely changes the legal playing field. It reverses a massive victory that the pharmaceutical industry celebrated just two years ago.
If you are a parent or expecting a child, this news is incredibly confusing. Let's look at what actually happened in court, what the science actually says, and what you should do next.
Inside the Appeals Court Decision
To understand why these cases are back, you have to look at how federal courts handle expert scientific evidence.
In December 2024, U.S. District Judge Denise Cote in Manhattan threw out the federal multidistrict litigation. She ruled that the scientific experts put forward by the plaintiffs relied on flawed, unreliable methods. She essentially closed the door on the families.
The appeals court just kicked that door wide open again.
Writing for a three-judge panel, Circuit Judge Guido Calabresi stated that the district court judge went too far. The appeals court ruled that Judge Cote improperly acted as a scientist instead of a legal gatekeeper.
Judge Calabresi wrote that the expert testimony presented by the families reflected accepted scientific methodologies. He made a point to emphasize that scientists can, and often do, disagree on complex data. In the eyes of the appeals court, a jury should hear these arguments, not a single judge.
The court was careful to clarify its role. The judges did not decide whether acetaminophen actually causes autism or ADHD. They simply ruled that the experts hired by the families have enough scientific credibility to present their findings in court.
The Three Scientists Bringing the Cases Back to Life
This entire legal battle hinges on whether the plaintiffs' expert witnesses are using junk science or legitimate research methods. By reviving the lawsuits, the Second Circuit gave a major stamp of credibility to three specific researchers.
- Dr. Andrea Baccarelli: The dean of Harvard University’s School of Public Health.
- Dr. Eric Hollander: A professor of psychiatry at the Albert Einstein College of Medicine.
- Dr. Brandon Pearson: A toxicologist at Columbia University.
These are not fringe actors. They are leading minds at some of the most prestigious institutions in the world.
The defense argued that these scientists cherry-picked data to create a link where none exists. The appeals court disagreed. It ruled that while their conclusions are debatable, their methods are standard in the scientific community.
This distinction is massive. In mass tort litigation, getting your experts in front of a jury is more than half the battle. Now that these three scientists are allowed to testify, the lawsuits can proceed toward actual trials.
How We Got Here from the 2024 Dismissal
This litigation has been a wild roller coaster.
It started gaining massive momentum around 2022. Hundreds of families joined together, claiming that manufacturers and retailers failed to warn them about the neurodevelopmental risks of prenatal acetaminophen exposure. They pointed to several observational studies.
The corporate defendants—which include Kenvue, along with major retailers like Walmart, CVS, Walgreens, Target, and Kroger—pushed back hard. They argued that there is no proof of causation.
When Judge Cote dismissed the cases in late 2024, it looked like the end of the road for the federal lawsuits. Many families started shifting their focus to state-level courts, where rules on expert testimony can sometimes be more flexible.
But the plaintiffs appealed the federal dismissal. They waited. Then, the landscape shifted.
During late 2025, public attention on the issue spiked again. Even political figures and top health officials began publicly questioning the safety of acetaminophen during pregnancy. This kept the pressure high.
Now, with the Second Circuit's ruling, the federal cases are alive and well. The defense is suddenly facing the prospect of facing juries in high-stakes trials.
Understanding the Daubert Standard and the Judge Role
Why did the appeals court override Judge Cote? It comes down to a legal rule called the Daubert standard.
Under federal law, a trial judge acts as a gatekeeper. They must ensure that any scientific expert testimony admitted at trial is both relevant and reliable. It is meant to keep "snake oil" salesmen out of the courtroom.
But there is a fine line. A judge is supposed to evaluate the methodology of the scientist, not the conclusion.
Judge Calabresi's 64-page decision argued that Judge Cote crossed that line. By deciding that the experts' conclusions were too weak, she essentially took the decision away from the jury.
The appeals court reminded the legal world that when reputable scientists interpret the same data differently, the jury should decide who is more persuasive. It is a subtle legal distinction with multibillion-dollar consequences.
What the Science Actually Tells Us
If you are looking for a simple, clear-cut answer on whether Tylenol causes autism, you won't find one. The science is incredibly messy.
Several peer-reviewed studies have found a statistical association between prenatal acetaminophen use and neurodevelopmental issues.
For example, a study published in JAMA Psychiatry in 2020 analyzed cord blood samples from 996 mother-infant pairs. It found that children with higher levels of acetaminophen in their cord blood were more likely to be diagnosed with ADHD or autism later in childhood.
Another observational study published in the American Journal of Epidemiology suggested that prenatal exposure might increase the relative risk of ADHD by about 34% and autism spectrum disorder by 19%.
These numbers sound terrifying. But you have to look at the limitations of these studies.
First, they are observational. They show correlation, not causation.
It is incredibly difficult to separate the effects of the drug from the reason the mother took the drug in the first place. This is called confounding by indication. If a pregnant mother takes Tylenol to treat a severe, high fever, was it the Tylenol that affected fetal brain development, or was it the high fever itself?
We know that severe maternal fevers and infections during pregnancy are linked to developmental issues.
Furthermore, a massive 2024 Swedish study analyzing data from 2.5 million children found no causal link between prenatal acetaminophen use and autism or ADHD when comparing siblings. When researchers compared siblings—where one was exposed to Tylenol in the womb and the other was not—the statistical link disappeared. This suggests that shared genetic and environmental factors, rather than the drug itself, explain the association.
The Medical Dilemma for Expectant Mothers
This legal battle has created a massive headache for doctors.
The American College of Obstetricians and Gynecologists (ACOG) still recommends acetaminophen as the first-line treatment for pain and fever during pregnancy.
Why? Because the alternatives are worse.
Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or aspirin are generally avoided during pregnancy, especially in the second half, because they can cause serious heart and kidney complications in the fetus.
Untreated fevers are also incredibly dangerous. A high maternal fever can lead to birth defects, miscarriage, or premature labor.
If pregnant women stop taking Tylenol out of fear, they might leave severe pain or fevers untreated, which could cause direct, proven harm to their babies.
The medical consensus remains that acetaminophen is the safest known option, provided it is used at the lowest effective dose for the shortest possible time.
What Happens Next for Families and Corporate Defendants
The revival of these lawsuits is a financial disaster for Kenvue.
Kenvue was spun off by Johnson & Johnson in 2023. Just last year, Kenvue agreed to be acquired by Kimberly-Clark for more than $40 billion. Now, this massive legal liability is hanging over the deal again.
On the day of the court decision, Kenvue's stock immediately dipped. Bloomberg Intelligence previously estimated that if these lawsuits proceed and succeed, they could cost the defendants billions of dollars in potential settlements.
For families who have filed lawsuits, this ruling is a massive validation. It means their day in court is finally coming.
For the average consumer, the immediate impact will likely be seen on product packaging. If these lawsuits continue to progress, we might start seeing explicit warning labels on over-the-counter pain relievers warning pregnant women about potential neurodevelopmental risks, even if the science remains highly debated.
Your Practical Next Steps
If you are currently pregnant or planning a pregnancy, do not panic. Do not make drastic medical decisions based on legal headlines.
Here is what you should actually do:
- Talk to your OB-GYN: Never stop taking a medication or leave a high fever untreated without consulting your doctor. They understand your specific health profile and can help you weigh the risks.
- Minimize your usage: If you do need to use acetaminophen, use the smallest possible dose that works. Avoid using it daily or for extended periods unless explicitly directed by a physician.
- Track your symptoms: Keep a simple log of when you take pain relievers, the dosage, and the reason you took them. This is good practice for any medication used during pregnancy.
- Stay updated on the litigation: If you believe your child's diagnosis is directly linked to heavy prenatal Tylenol use, consult with a qualified mass tort attorney to understand your options, as the window for filing claims in light of this new ruling may shift.
The legal system is built to determine liability, not absolute scientific truth. As this court battle restarts, expect to hear a lot of loud, frightening claims from both sides. Keep your focus on the actual clinical guidance of your medical team.
